Amgen bought ChemoCentryx ChemoCentryx from 10/20/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Amgen completed its acquisition of ChemoCentryx for $3.7 billion, or $52 per share.

ChemoCentryx

Review

Source:

{source} pictogram

investors.amgen.com

Vladimir Petenev

News editor

Write your comment first

News feed

Kamaz will produce the Atom electric car at the Moskvich plant

6/1/23 KMAZ

Fesco and RZD Logistics to launch cargo delivery from China in luggage cars

6/1/23 FESH

The Macy’s announced a quarterly dividend

6/1/23 M

Macy's reported 3 months of 2023

6/1/23 M

MTS consolidated 100% of Gulfstream, a provider of security services and smart home solutions

6/1/23 MTSS

SPB Exchange will admit to trading 14 new ETFs

6/1/23 SPBE

Rosseti plans to issue additional shares to acquire regional assets

6/1/23 FEES

Segezha Group sees great prospects for business in North Africa

6/1/23 SGZH

Polymetal approves sites for autoclave in Kazakhstan

6/1/23 POLY

Salesforce has reported for 3 months of fiscal year 2024

6/1/23 CRM